Apellis Pharmaceuticals Inc at Citi BioPharma Conference Transcript
Welcome, everyone. Thanks for joining. I'm Yigal Nochomovitz, I'm one of the biotech analysts here at Citi. And it's my great pleasure to have with me the senior management from Apellis Pharma, Cedric Francois, CEO and Co-Founder; Adam Townsend, Chief Commercial Officer; Tim Sullivan, Chief Financial Officer.
So welcome all of you. Cedric, it's been a long road since we first met back in Louisville, I think in the summer of 2015 when you were still private. A lot has happened since then in terms of clinical progress, expansion of the pipeline. So tell us how do you see -- how is the mission of Apellis evolved? How would you grade yourself against the objectives that you set out for yourself back in the early days 7 years ago.
Well, I'll let others grade us. But it's been a fantastic ride, of course, right? I mean when we started Apellis about a decade ago, we set out initially on a mission to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
